Long-Term Incidence of Stroke and Dementia in ASCOT | Zendy

William Whiteley | Zendy; Ajay Gupta | Zendy; Thomas Godec | Zendy; Somayeh Rostamian | Zendy; Andrew J. O. Whitehouse | Zendy; Judy A Mackay | Zendy; Peter Sever | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Incidence of Stroke and Dementia in ASCOT

Author(s) -

William Whiteley,

Ajay Gupta,

Thomas Godec,

Somayeh Rostamian,

Andrew J. O. Whitehouse,

Judy A Mackay,

Peter Sever

Publication year - 2021

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.120.033489

Subject(s) - medicine , stroke (engine) , atorvastatin , dementia , amlodipine , hazard ratio , atenolol , placebo , blood pressure , vascular dementia , regimen , physical therapy , confidence interval , disease , mechanical engineering , alternative medicine , pathology , engineering

Management of stroke risk factors might reduce later dementia. In ASCOT (Anglo-Scandinavian Outcome Trial), we determined whether dementia or stroke were associated with different blood pressure (BP)–lowering regimens; atorvastatin or placebo; and mean BP, BP variability, and mean cholesterol levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research